Pfizer International Growth Study (KIGS) - Protocol TRN 87-052-45 (CCID A6281276)

Sponsor: Pfizer

Location(s): United States


This is a multicenter observational database and study to gather information about children’s growth response and long-term effects from growth hormone replacement therapy using Genotropin®, a recombinant DNA hormone from Pfizer. This study provides information to doctors prescribing Genotropin to treat children and adolescents, ultimately helping physicians to use it more effectively.